Article | April 20, 2023

2023: Everything That Brought Us Where We Are Now…And How It Will Help Us Achieve New Heights

By Robert Bloder, Ascendia Pharma

Clean room industrial laboratory manufacturing GettyImages-1344379591

Reducing costs and ensuring on-time delivery is a top priority for pharmaceutical companies aiming to bring their product to market ahead of their competition. Partnering with a CDMO that utilizes innovative technologies and a team of highly skilled, experienced scientists to advance a product through the development lifecycle with speed is key.

Ascendia Pharma’s innovative technology platforms enable them to work with lipid nanoparticles (LNPs) to enhance solubility and improve bioavailability – all while maintaining stability and product critical attributes – resulting in highly optimized drug formulation and delivery. Ascendia will also soon be offering Phase III and Commercial Supply Products, allowing them to produce prefilled syringes, vials, cartridges, and other deliverables at an even larger scale. Discover the opportunities for optimized drug formulation and delivery, as well as the commercial supply products on the horizon that can advance your therapy to the clinic and beyond.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Pharmaceutical Online